FIFTH AMENDMENTCorcept Therapeutics Inc • August 4th, 2020 • Pharmaceutical preparations
THIS FIFTH AMENDMENT (the "Fifth Amendment") is made and entered into as of June 17, 2020 by and between Exponent Realty, LLC, a Delaware limited liability company ("Landlord"), and Corcept Therapeutics Incorporated, a Delaware corporation ("Tenant").
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • August 4th, 2020 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of August 3, 2020 (the “Effective Date”) is entered into by and between Joseph Douglas (“J.D.”) Lyon, Chief Accounting Officer (“CAO”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • August 4th, 2020 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of August 3, 2020 (the “Effective Date”) is entered into by and between Hazel Hunt, Chief Scientific Officer (“CSO”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • August 4th, 2020 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of August 3, 2020 (the “Effective Date”) is entered into by and between Sean Maduck, Chief Commercial Officer (“CCO”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
